Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: A meta-analysis

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Wu, Jing Xun ^a   Zhao, Yuan Yuan ^b   Wu, Xuan ^c   An, Han Xiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CNKI DATABASE; CONFIDENCE INTERVAL; EMBASE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; INFORMATION RETRIEVAL; LYMPH NODE METASTASIS; MEDLINE; META ANALYSIS (TOPIC); OVERALL SURVIVAL; RISK ASSESSMENT; STOMACH CANCER; TUMOR DIFFERENTIATION; WEB OF SCIENCE; GENE EXPRESSION REGULATION; GENETICS; META ANALYSIS; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS;

ANTIGENS, CD24; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84917677490     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114746     Document Type: Article

References (39)

1. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150.
2. Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N, et al. (2000) Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 89: 1418-1424.
3. Hundahl SA, Menck HR, Mansour EG, Winchester DP (1997) The National Cancer Data Base report on gastric carcinoma. Cancer 80: 2333-2341.
4. Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, et al. (2006) Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer 9: 51-66.
5. Serlin O, Keehn RJ, Higgins GA Jr, Harrower HW, Mendeloff GL (1977) Factors related to survival following resection for gastric carcinoma: analysis of 903 cases. Cancer 40: 1318-1329.
6. Siewert JR, Bottcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: tenyear results of the German Gastric Cancer Study. Annals of surgery 228: 449-461.
7. Chen M, Geng JG (2006) P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Archivum immunologiae et therapiae experimentalis 54: 75-84.
8. Fischer GF, Majdic O, Gadd S, Knapp W (1990) Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules. J Immunol 144: 638-641.
9. Pirruccello SJ, LeBien TW (1986) The human B cell-associated antigen CD24 is a single chain sialoglycoprotein. J Immunol 136: 3779-3784.
10. Sammar M, Aigner S, Hubbe M, Schirrmacher V, Schachner M, et al. (1994) Heat-stable antigen (CD24) as ligand for mouse P-selectin. International immunology 6: 1027-1036.
11. Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, et al. (2005) CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer research 65: 10783-10793.
12. Li O, Zheng P, Liu Y (2004) CD24 expression on T cells is required for optimal T cell proliferation in lymphopenic host. The Journal of experimental medicine 200: 1083-1089.
13. Nielsen PJ, Lorenz B, Muller AM, Wenger RH, Brombacher F, et al. (1997) Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice. Blood 89: 1058-1067.
14. Kadmon G, von Bohlen und Halbach F, Schachner M, Altevogt P (1994) Differential, LFA-1-sensitive effects of antibodies to nectadrin, the heat-stable antigen, on B lymphoblast aggregation and signal transduction. Biochemical and biophysical research communications 198: 1209-1215.
15. Suzuki T, Kiyokawa N, Taguchi T, Sekino T, Katagiri YU, et al. (2001) CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system. J Immunol 166: 5567-5577.
16. Kristiansen G, Sammar M, Altevogt P (2004) Tumour biological aspects of CD24, a mucin-like adhesion molecule. Journal of molecular histology 35: 255-262.
17. Su MC, Hsu C, Kao HL, Jeng YM (2006) CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Cancer letters 235: 34-39.
18. Aigner S, Ramos CL, Hafezi-Moghadam A, Lawrence MB, Friederichs J, et al. (1998) CD24 mediates rolling of breast carcinoma cells on P-selectin. Faseb J 12: 1241-1251.
19. Friederichs J, Zeller Y, Hafezi-Moghadam A, Grone HJ, Ley K, et al. (2000) The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer research 60: 6714-6722.
20. Lee JH, Kim SH, Lee ES, Kim YS (2009) CD24 overexpression in cancer development and progression: a meta-analysis. Oncology reports 22: 1149-1156.
21. Bektas S, Bahadir B, Ucan BH, Ozdamar SO (2010) CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance. Pathol Oncol Res 16: 569-577.
22. Chou YY, Jeng YM, Lee TT, Hu FC, Kao HL, et al. (2007) Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma. Annals of surgical oncology 14: 2748-2758.
23. Darwish NS, Kim MA, Chang MS, Lee HS, Lee BL, et al. (2004) Prognostic significance of CD24 expression in gastric carcinoma. Cancer Res Treat 36: 298-302.
24. Jian (2009) The expression and clinical significance of CD24 in human gastric carcinoma. Journal of Chongqing Medical University 34: 1348-1350.
25. Liu X, Yu H, Cai H, Wang Y (2014) Expression of CD24, p21, p53, and c-myc in alpha-fetoproteinproducing gastric cancer: Correlation with clinicopathologic characteristics and survival. Journal of surgical oncology 109: 859-864.
26. Niu (2009) Expression and significaace of CD24 in precancerous lesion and gastric cancer. Journal of Nongken Medicine 31: 129-132.
27. Takahashi M, Nakajima M, Ogata H, Domeki Y, Ohtsuka K, et al. (2013) CD24 expression is associated with progression of gastric cancer. Hepato-gastroenterology 60: 653-658.
28. Yang S-b, Xiao L-b, Feng-feng X (2012) Expression of EPCAM, CD44 and CD24 in gastric cancer tissues and its clinical significance. Chinese Journal of Pathophysiology 28: 1224-1229.
29. Yao H-l, YANG Z-l, LI Y-g, Wu W-h, Li S-z, et al. (2008) Expression and significance of CD24 and CD44v6 in benign and malignant lesions of stomach. Chinese Journal of Pathophysiology 24: 1629-1631.
30. Lauren P (1965) The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. an Attempt at a Histo-Clinical Classification. Acta pathologica et microbiologica Scandinavica 64: 31-49.
31. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8: 16.
32. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. (2011) The Newcatsle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. Ottawa: Ottawa Hospital Research Institute Available: www.ohri.ca/programs/clinical-epidemiology/oxford.htm accessed April 8, 2014.
33. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controlled clinical trials 7: 177-188.
34. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 22: 719-748.
35. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
36. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed 315: 629-634.
37. Aigner S, Sthoeger ZM, Fogel M, Weber E, Zarn J, et al. (1997) CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89: 3385-3395.
38. Lynch HT, Grady W, Suriano G, Huntsman D (2005) Gastric cancer: new genetic developments. Journal of surgical oncology 90: 114-133; discussion 133.
39. Ming SC (1998) Cellular and molecular pathology of gastric carcinoma and precursor lesions: A critical review. Gastric Cancer 1: 31-50.